Been seeing a lot of buzz around Tilray (TLRY) lately, so let me just lay out why I'm not touching this one right now.

On the surface, the story sounds decent enough. Tilray positions itself as this lifestyle company spanning cannabis, hemp, and alcohol. And yeah, they've been growing revenue aggressively since 2021, picking up brands left and right. The cannabis legalization wave should theoretically be a tailwind, right?

But here's the thing — the company still isn't profitable. Down 99% from its all-time high, and management keeps chasing growth through acquisitions instead of actually making money. That's a red flag for me.

What really concerns investors watching this closely is the share dilution. Every time they buy another brand with stock or raise cash, they're diluting existing shareholders. And when you're not profitable to begin with, spreading earnings across more and more shares just makes the math worse. They've already had to write down assets across pretty much every division.

Look, I get the temptation. Cannabis is legal in more places, the beverage angle sounds innovative, wellness is hot. But Tilray is basically the poster child for a company that's trying to buy its way to growth instead of actually building a sustainable business model.

Don't even think about it until they prove they can turn a profit. Sometimes the smartest investment decision is knowing when not to invest. That's the don't tread on me approach to your portfolio — make your own calls based on fundamentals, not hype. The company needs to show sustainable earnings before it deserves your capital.